PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1383449
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1383449
Microarray Market Forecasts to 2030 - Global Analysis By Product (Consumables, Instruments and Software & Services), Type, Application, End User and By Geography
According to Stratistics MRC, the Global Microarray Market is accounted for $4.70 billion in 2023 and is expected to reach $9.04 billion by 2030 growing at a CAGR of 9.8% during the forecast period. In genomics and molecular biology, microarrays are an effective technology that allow for the high-throughput, simultaneous investigation of many genes, proteins, or other substances. The market offers a broad variety of applications in research, diagnostics, and drug development and comprises many types of microarrays, including DNA, protein, and tissue microarrays. Custom microarrays are created by several organizations and researchers to meet their unique research requirements.
According to a research study published by the Royal Society of Chemistry in 2019, a portable fluorescence microarray imaging system that connects to a smartphone has been used for the detection of breast cancer gene expression.
Market Dynamics:
Driver:
Rise in the usage of microarrays in various applications
The market for microarrays has grown as a result of the growing use of microarrays in various applications. The need for microarray goods and services has increased as more scientists and organizations use them for clinical diagnostics, proteomics, genomics, and other areas. These days, microarrays are employed in many more fields, such as drug development, proteomics, clinical diagnostics, genomics, and environmental monitoring due to this diversity, the market is now more resilient to changes in certain industries and has been able to develop continuously. Drug development relies heavily on microarrays because they make target identification, toxicity assessment, and biomarker discovery easier.
Restraint:
Competition from next-generation sequencing (NGS)
Next-generation sequencing technologies can give complete molecular and genomic data; they have become more and more popular. They have so reduced microarrays' market share across a range of applications. Because of Next-generation sequencing breadth of information and high-throughput sequencing capabilities, researchers and physicians frequently use it. When considering technologies, it is frequently thought to be more potent and sophisticated than microarrays. This idea may discourage the use of microarrays in favour of next-generation sequencing in research and other settings, which might stunt the expansion of the microarray business.
Opportunity:
Growing awareness regarding personalized medicines
Molecular profiling of individual patients is the foundation of personalized medicine, which customizes medicinal interventions. In order to produce genetic and molecular data particular to each patient, microarrays are essential. The growing awareness among patients and healthcare professionals of the potential advantages of customized medicine has led to a surge in demand for these technologies. In the realm of customized medicine, interdisciplinary collaboration between researchers, healthcare practitioners, and biotechnology businesses is becoming more widespread.
Threat:
High maintenance
Microarray technology adoption may be hindered by the lack of qualified workers. If research organizations and clinical labs lack the staff with the necessary skills to properly run the technology, they can be reluctant to invest in microarray platforms. The analysis of microarray data might be challenging and call for bioinformatics knowledge. A shortage of qualified experts might lead to ineffective data processing, which would postpone research results, misunderstand them, and decrease scientific output thus hampering the market growth.
COVID-19 Impact
Through the investigation of host responses to the virus, patient gene expression alterations, and the creation of diagnostic tests, microarrays contributed to COVID-19 research. As a result, there was a rise in demand for virus-specific microarray-based tests. Thus, the pandemic caused changes in certain regions' objectives for financing research, with an emphasis on developing vaccines and researching infectious diseases. Furthermore, the market for microarrays may grow if more money is invested in life sciences research, like as proteomics and genomics, once the pandemic's acute phase has passed.
The protein microarrays segment is expected to be the largest during the forecast period
The protein microarrays segment is estimated to have a lucrative growth, as these proteomics research, protein microarrays are an effective and adaptable tool for examining the characteristics, relationships, and roles of proteins. Protein microarrays enable high-throughput analysis of the binding interactions of proteins and other molecules, much to DNA microarrays, which are used to examine gene expression. The advancement of protein microarray technology has produced increasingly sophisticated systems with improved sensitivity, specificity, and throughput.
The diseases diagnostics segment is expected to have the highest CAGR during the forecast period
The diseases diagnostics segment is anticipated to witness the highest CAGR growth during the forecast period, because the single nucleotide polymorphisms (SNPs) linked to genetic disorders, cancer, and infectious illnesses, as well as chromosomal abnormalities, are all found using these microarrays. These microarrays investigate protein-protein interactions, gene expression patterns, and protein localization in a variety of disorders using tissue slices or cultured cells. Moreover these diagnostic microarrays allow for customized treatment plans based on a patient's genetic or molecular profile in the age of personalized medicine thereby boosting the market growth.
Region with largest share:
Asia Pacific is projected to hold the largest market share during the forecast period owing to the rising demand for cutting-edge healthcare solutions as well as enhanced genomics and personalized medicine research and development efforts are responsible for this expansion. The Asia Pacific area is home to several academic institutions, research labs, and biotechnology corporations that are actively involved in microarray research and development. This involves the creation of personalized microarrays for particular uses and the identification of biomarkers for a range of illnesses.
Region with highest CAGR:
North America is projected to have the highest CAGR over the forecast period; owing to one of the biggest and most developed markets for microarray technology. Particularly, the US is a significant centre for microarray creation and research. The North American microarray market is occupied by a number of multinational and local businesses that offer microarray platforms, reagents, and services. Agilent Technologies, Illumina, Thermo Fisher Scientific, PerkinElmer, and many more are some of the major companies in this sector are driving the market growth in this region.
Key players in the market
Some of the key players profiled in the Microarray Market include: Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., PerkinElmer, Inc., Bio-Rad Laboratories, GE Healthcare, Molecular Devices, LLC, Affymetrix, Merck & Co., Inc., Arrayit Corporation, Microarrays; Inc., NextGen Sciences, bioMerieux SA, RayBiotech Life, Inc, PathogenDx, Diasorin Group, Schott Minifab, Full Moon Biosystems.Inc and CapitalBio Technology Co, Ltd
Key Developments:
In October 2023, Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Meridian™ EX System an electron-beam-based failure analysis solution designed to enable precise fault localization on advanced semiconductor logic technologies.
In October 2023, Thermo Fisher Scientific announced a companion diagnostic (CDx) partnership with Boehringer Ingelheim. Through this collaboration, the companies will work to develop CDx tests to help identify patients with non-small cell lung cancer (NSCLC) with specific genomic mutations.
In September 2023, Agilent Technologies Inc recently signed a Research Collaboration Agreement (RCA) with the National Cancer Centre Singapore (NCCS) outlining their collaboration to accelerate translational cancer research on the genomic landscape of Asian-prevalent cancers over the next two years.
Products Covered:
- Consumables
- Instruments
- Software & Services
Types Covered:
- Protein Microarrays
- DNA Microarrays
- Other Microarrays
Applications Covered:
- Drug Discovery
- Diseases Diagnostics
- Research Applications
- Agriculture
- Other Applications
End Users Covered:
- Pharmaceutical & Biotechnology Companies
- Research & Academic Institutes
- Diagnostic Laboratories
- Other End Users
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Product Analysis
- 3.7 Application Analysis
- 3.8 End User Analysis
- 3.9 Emerging Markets
- 3.10 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Microarray Market, By Product
- 5.1 Introduction
- 5.2 Consumables
- 5.3 Instruments
- 5.4 Software & Services
6 Global Microarray Market, By Type
- 6.1 Introduction
- 6.2 Protein Microarrays
- 6.3 DNA Microarrays
- 6.4 Other Microarrays
7 Global Microarray Market, By Application
- 7.1 Introduction
- 7.2 Drug Discovery
- 7.3 Diseases Diagnostics
- 7.4 Research Applications
- 7.5 Agriculture
- 7.6 Other Applications
8 Global Microarray Market, By End User
- 8.1 Introduction
- 8.2 Pharmaceutical & Biotechnology Companies
- 8.3 Research & Academic Institutes
- 8.4 Diagnostic Laboratories
- 8.5 Other End Users
9 Global Microarray Market, By Geography
- 9.1 Introduction
- 9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
- 9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
- 9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa
10 Key Developments
- 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 10.2 Acquisitions & Mergers
- 10.3 New Product Launch
- 10.4 Expansions
- 10.5 Other Key Strategies
11 Company Profiling
- 11.1 Agilent Technologies, Inc.
- 11.2 Thermo Fisher Scientific, Inc.
- 11.3 Illumina, Inc.
- 11.4 PerkinElmer, Inc.
- 11.5 Bio-Rad Laboratories
- 11.6 GE Healthcare
- 11.7 Molecular Devices, LLC
- 11.8 Affymetrix
- 11.9 Merck & Co., Inc.
- 11.10 Arrayit Corporation
- 11.11 Microarrays; Inc.
- 11.12 NextGen Sciences
- 11.13 bioMerieux SA
- 11.14 RayBiotech Life, Inc
- 11.15 PathogenDx
- 11.16 Diasorin Group
- 11.17 Schott Minifab
- 11.18 Full Moon Biosystems.Inc
- 11.19 CapitalBio Technology Co, Ltd
List of Tables
- Table 1 Global Microarray Market Outlook, By Region (2021-2030) ($MN)
- Table 2 Global Microarray Market Outlook, By Product (2021-2030) ($MN)
- Table 3 Global Microarray Market Outlook, By Consumables (2021-2030) ($MN)
- Table 4 Global Microarray Market Outlook, By Instruments (2021-2030) ($MN)
- Table 5 Global Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
- Table 6 Global Microarray Market Outlook, By Type (2021-2030) ($MN)
- Table 7 Global Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
- Table 8 Global Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
- Table 9 Global Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
- Table 10 Global Microarray Market Outlook, By Application (2021-2030) ($MN)
- Table 11 Global Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
- Table 12 Global Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
- Table 13 Global Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
- Table 14 Global Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
- Table 15 Global Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 16 Global Microarray Market Outlook, By End User (2021-2030) ($MN)
- Table 17 Global Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
- Table 18 Global Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
- Table 19 Global Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
- Table 20 Global Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 21 North America Microarray Market Outlook, By Country (2021-2030) ($MN)
- Table 22 North America Microarray Market Outlook, By Product (2021-2030) ($MN)
- Table 23 North America Microarray Market Outlook, By Consumables (2021-2030) ($MN)
- Table 24 North America Microarray Market Outlook, By Instruments (2021-2030) ($MN)
- Table 25 North America Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
- Table 26 North America Microarray Market Outlook, By Type (2021-2030) ($MN)
- Table 27 North America Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
- Table 28 North America Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
- Table 29 North America Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
- Table 30 North America Microarray Market Outlook, By Application (2021-2030) ($MN)
- Table 31 North America Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
- Table 32 North America Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
- Table 33 North America Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
- Table 34 North America Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
- Table 35 North America Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 36 North America Microarray Market Outlook, By End User (2021-2030) ($MN)
- Table 37 North America Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
- Table 38 North America Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
- Table 39 North America Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
- Table 40 North America Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 41 Europe Microarray Market Outlook, By Country (2021-2030) ($MN)
- Table 42 Europe Microarray Market Outlook, By Product (2021-2030) ($MN)
- Table 43 Europe Microarray Market Outlook, By Consumables (2021-2030) ($MN)
- Table 44 Europe Microarray Market Outlook, By Instruments (2021-2030) ($MN)
- Table 45 Europe Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
- Table 46 Europe Microarray Market Outlook, By Type (2021-2030) ($MN)
- Table 47 Europe Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
- Table 48 Europe Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
- Table 49 Europe Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
- Table 50 Europe Microarray Market Outlook, By Application (2021-2030) ($MN)
- Table 51 Europe Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
- Table 52 Europe Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
- Table 53 Europe Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
- Table 54 Europe Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
- Table 55 Europe Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 56 Europe Microarray Market Outlook, By End User (2021-2030) ($MN)
- Table 57 Europe Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
- Table 58 Europe Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
- Table 59 Europe Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
- Table 60 Europe Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 61 Asia Pacific Microarray Market Outlook, By Country (2021-2030) ($MN)
- Table 62 Asia Pacific Microarray Market Outlook, By Product (2021-2030) ($MN)
- Table 63 Asia Pacific Microarray Market Outlook, By Consumables (2021-2030) ($MN)
- Table 64 Asia Pacific Microarray Market Outlook, By Instruments (2021-2030) ($MN)
- Table 65 Asia Pacific Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
- Table 66 Asia Pacific Microarray Market Outlook, By Type (2021-2030) ($MN)
- Table 67 Asia Pacific Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
- Table 68 Asia Pacific Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
- Table 69 Asia Pacific Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
- Table 70 Asia Pacific Microarray Market Outlook, By Application (2021-2030) ($MN)
- Table 71 Asia Pacific Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
- Table 72 Asia Pacific Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
- Table 73 Asia Pacific Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
- Table 74 Asia Pacific Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
- Table 75 Asia Pacific Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 76 Asia Pacific Microarray Market Outlook, By End User (2021-2030) ($MN)
- Table 77 Asia Pacific Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
- Table 78 Asia Pacific Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
- Table 79 Asia Pacific Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
- Table 80 Asia Pacific Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 81 South America Microarray Market Outlook, By Country (2021-2030) ($MN)
- Table 82 South America Microarray Market Outlook, By Product (2021-2030) ($MN)
- Table 83 South America Microarray Market Outlook, By Consumables (2021-2030) ($MN)
- Table 84 South America Microarray Market Outlook, By Instruments (2021-2030) ($MN)
- Table 85 South America Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
- Table 86 South America Microarray Market Outlook, By Type (2021-2030) ($MN)
- Table 87 South America Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
- Table 88 South America Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
- Table 89 South America Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
- Table 90 South America Microarray Market Outlook, By Application (2021-2030) ($MN)
- Table 91 South America Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
- Table 92 South America Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
- Table 93 South America Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
- Table 94 South America Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
- Table 95 South America Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 96 South America Microarray Market Outlook, By End User (2021-2030) ($MN)
- Table 97 South America Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
- Table 98 South America Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
- Table 99 South America Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
- Table 100 South America Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 101 Middle East & Africa Microarray Market Outlook, By Country (2021-2030) ($MN)
- Table 102 Middle East & Africa Microarray Market Outlook, By Product (2021-2030) ($MN)
- Table 103 Middle East & Africa Microarray Market Outlook, By Consumables (2021-2030) ($MN)
- Table 104 Middle East & Africa Microarray Market Outlook, By Instruments (2021-2030) ($MN)
- Table 105 Middle East & Africa Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
- Table 106 Middle East & Africa Microarray Market Outlook, By Type (2021-2030) ($MN)
- Table 107 Middle East & Africa Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
- Table 108 Middle East & Africa Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
- Table 109 Middle East & Africa Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
- Table 110 Middle East & Africa Microarray Market Outlook, By Application (2021-2030) ($MN)
- Table 111 Middle East & Africa Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
- Table 112 Middle East & Africa Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
- Table 113 Middle East & Africa Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
- Table 114 Middle East & Africa Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
- Table 115 Middle East & Africa Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 116 Middle East & Africa Microarray Market Outlook, By End User (2021-2030) ($MN)
- Table 117 Middle East & Africa Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
- Table 118 Middle East & Africa Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
- Table 119 Middle East & Africa Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
- Table 120 Middle East & Africa Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
